BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Phase 2 Results for EntreMed, Inc.'s Panzem(R) NCD Brain Cancer Study Presented at American Society of Clinical Oncology

  June 5, 2007

   · 

  5 min read
• Policy

  Pharmion Corporation Announces French ATU Granted for Use of Thalidomide for Elderly Patients With Untreated Multiple Myeloma

  June 5, 2007

   · 

  8 min read
• Drug Development

  Cell Therapeutics, Inc. XYOTAX(TM) More Cost Effective With Fewer Side Effects Than Gemcitabine or Vinorelbine in Treating Non-Small Cell Lung Cancer

  June 5, 2007

   · 

  5 min read
• Drug Development

  Alexion Pharmaceuticals Inc. Release: Soliris(TM) Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes

  June 5, 2007

   · 

  10 min read
• Business

  Nventa Biopharmaceuticals Corporation Hires Vice President of Corporate Development

  June 5, 2007

   · 

  1 min read
• Pharm Country

  AstraZeneca PLC, Bristol-Myers Squibb Company, Johnson & Johnson, Merck & Co., Inc. & Pfizer Inc. Among Companies Planning to Attend Windhover Information Inc.'s 14th Annual Euro-Biotech Forum

  June 5, 2007

   · 

  1 min read
• Business

  Meridian Bioscience, Inc. Increases Earnings Per Share and Net Sales Guidance for Fiscal 2007

  June 5, 2007

   · 

  1 min read
• BioMidwest

  Medtronic, Inc. to Participate in the Goldman, Sachs & Co. Global Healthcare Conference

  June 5, 2007

   · 

  1 min read
• Drug Development

  Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control

  June 5, 2007

   · 

  1 min read
• BioMidwest

  Copernicus Therapeutics, Inc.’ Nanoparticle Technology Applied to siRNA

  June 5, 2007

   · 

  1 min read